- In July 2026, PTC Inc. reported third‑quarter results showing revenue of US$600.05 million and net income of US$118.78 million, while issuing fourth‑quarter revenue guidance of US$630 million to US$690 million and earnings per share guidance of US$0.94 to US$1.70.
- PTC also raised its full‑year 2026 revenue and earnings guidance and completed a share repurchase of 10,628,265 shares for about US$1.57 billion, highlighting management’s confidence in its performance and capital allocation approach.
- We’ll now examine how PTC’s raised full‑year outlook and improved execution, particularly in AI‑enabled offerings, affects its investment narrative.
AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
PTC Investment Narrative Recap
To own PTC, you need to believe its AI‑enabled product lifecycle platform can keep growing recurring revenue while the SaaS transition and competitive pressure remain manageable. The latest quarter shows solid execution on ARR and guidance, but weaker year‑on‑year Q3 revenue means the near term catalyst around AI‑driven adoption still shares the spotlight with a key risk: potential lumpiness in large customer budgets that could slow new bookings.
The most relevant update here is PTC’s higher full year 2026 revenue and EPS guidance to US$2,690 million to US$2,750 million and US$8.46 to US$9.18. This raised outlook, alongside strong AI‑related product momentum, directly ties into the catalyst of improving go to market execution and SaaS mix, while also testing how resilient that thesis is if macro or competitive pressures start to bite more visibly.
Yet against this encouraging guidance, investors should be aware that growing dependence on a few core platforms could become a real issue if...
Read the full narrative on PTC (it's free!)
PTC's narrative projects $3.3 billion revenue and $894.9 million earnings by 2029. This requires 3.5% yearly revenue growth and an earnings decrease of about $305 million from $1.2 billion today.
Uncover how PTC's forecasts yield a $179.25 fair value, a 31% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already modeling about US$3.3 billion of revenue and US$809 million of earnings by 2029, so this stronger 2026 guidance may either support their view of faster AI driven platform adoption or highlight how exposed that thesis is to the risk that PTC’s reliance on Creo and Windchill becomes a drag instead of a strength over time.
Explore 6 other fair value estimates on PTC - why the stock might be worth just $131.43!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your PTC research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free PTC research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate PTC's overall financial health at a glance.
Seeking Other Investments?
Our top stock finds are flying under the radar-for now. Get in early:
- Find 55 companies with promising cash flow potential yet trading below their fair value.
- Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com